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Dynamic treatment regimes are a set of decision rules and each treatment decision is tailored over time
according to patients’ responses to previous treatments as well as covariate history. There is a growing
interest in development of correct statistical inference for optimal dynamic treatment regimes to handle
the challenges of nonregularity problems in the presence of nonrespondents who have zero-treatment
effects, especially when the dimension of the tailoring variables is high. In this article, we propose a high-
dimensional Q-learning (HQ-learning) to facilitate the inference of optimal values and parameters. The pro-
posedmethod allows us to simultaneously estimate the optimal dynamic treatment regimes and select the
important variables that truly contribute to the individual reward. At the same time, hard thresholding is
introduced in the method to eliminate the effects of the nonrespondents. The asymptotic properties for
the parameter estimators as well as the estimated optimal value function are then established by adjust-
ing the bias due to thresholding. Both simulation studies and real data analysis demonstrate satisfactory
performance for obtaining the proper inference for the value function for the optimal dynamic treatment
regimes. Supplementary materials for this article are available online.
1. Introduction
Heterogeneous responses to treatment, both across patients and
over time, are commonly observed for many diseases includ-
ing cancer, cardiovascular disease, and diabetes. Consequently,
treatment decisions need to be tailored not only to patients’ char-
acteristics, but also over time according to patients’ responses
to previous treatments. Such adaptive treatment strategies, also
referred as dynamic treatment regimes (DTRs), attractmore and
more attentions in concurrent clinical and statistical researches
(Chakraborty and Moodie 2013). In particular, one of the most
important goals is to infer the optimal dynamic treatment
regimes and evaluate the resulting value function, that is, the
expected reward outcome when this optimal rule is applied,
using empirical data evidence.
One of the most commonly used and effective approaches
to estimate the optimal DTRs in a multi-stage study is called
Q-learning, which is implemented through a backward recur-
sive fitting procedure (Watkins 1989). Specifically, a regression
model is fitted to estimate the conditional expectation of the
so-called Q-function at each stage, then the optimal treatment
at the current stage is estimated as the one maximizing this
conditional expectation. The Q-function for each state of the
Q-learning procedure is defined as the reward outcome incre-
ment in future stages when the optimal treatments are imple-
mented, given the current treatment and covariates. In practice,
the regression model is often based on a parametric linear
model with treatment by covariate interactions included.
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There are some key challenges with existing Q-learning
methods. First, with recent advances in technology, many prog-
nostic factors and intermediate outcomes for each individual
are collected but not all of them are useful for the treatment
decision-making process. The ability to identify and integrate
information that is relevant becomes critical when performing
regression in each stage of Q-learning. Qian andMurphy (2011)
proposed to estimate the conditional mean in Q-learning using
an L1-penalized regression and studied the error bound of the
value function for the estimated treatment regime. However, the
associated variable selection properties, such as selection con-
sistency, convergence rate, and weak convergence are not stud-
ied. Second, it is well known that obtaining proper inference
for the parameters indexing the optimal rules and the optimal
value function is difficult. The challenges in the above inference
problems arise when the optimal treatments in the latter stage
are not unique for at least some subjects in the population, that
is, nonrespondents, that fails traditional inferential approaches
(Robins 2004). To remedy the inference, various approaches
have been suggested, including hard thresholdmethod (Moodie
and Richardson (2010), also called Zeroing Instead of Plugging
In), soft threshold method (Chakraborty, Murphy, and Strecher
2010), and resampling method (Chakraborty, Laber, and Zhao
2013; Laber et al. 2014). However, the resampling method tends
to yield very conservative confidence intervals. More recently,
Luedtke and Van Der Laan (2016) proposed an online one-step
estimator to obtain the inference for the optimal value function
with split sampling. Although asymptotically valid, the result-
ing confidence interval for the value function can be wide due
to using partial sample for inference. Furthermore, it remains
unstudied and unclear how all these methods perform in high-
dimensional Q-learning setting.
In this article, we propose a high-dimensional Q-learning
(HQ-learning) to facilitate the inference of optimal values
and parameters. The proposed method makes use of both
sparsity regularization and hard-thresholding in Q-learning.
Specifically, we adopt a folded-concave penalty (Fan and Lv
2011) to estimate parameters at all stages to enforce sparsity.
Moreover, we remove from the regression the treatment effects
for the subjects whose treatment responses are smaller than a
given threshold. Through regularization, HQ-learning allows
us to simultaneously estimate the optimal dynamic treatment
regimes and select the important variables that truly contribute
to the individual reward at each stage. With hard thresholding,
we decrease the degree of nonregularity due to the nonunique-
ness of the optimal treatments for those nonrespondents. The
latter pays a price of introducing bias in the parameter and
value estimation, however, after estimating this bias, we are able
to remove this bias so still obtain proper inference for the value
function estimation.
The rest of the article is organized as follows. In Section 2,
we introduce the high-dimensional Q-learning and illustrate
with a two-stage DTR. Asymptotic distribution of the proposed
estimators is provided in Section 3 followed by the optimal
value estimation result and implementation issues in Section 4.
Simulation results and the application to STAR*D study are in
Sections 5 and 6. We wrap up the discussions in Section 7.
2. High-Dimensional Q-learning for Dynamic
Treatment Regimes
We first introduce high-dimensional Q-learning regression
models for estimating optimal dynamic treatment regimes in
multiple stage randomized studies. For simplicity, we only focus
on a two-stage randomized trial throughout this method but
generalization to more than two stages will be similar.
For tth stage (t = 1, 2), we let Ot denote all covariates mea-
sured prior to the tth stage and At ∈ {−1, 1} be a dichotomized
treatment assignment at the tth stage. Moreover, Rt denotes the
clinical reward right after the treatment at the tth stage, for
which a larger value of Rt is more desirable. Then in a two-
stage trial, (O1,A1,R1,O2,A2,R2) consists of all observed data
for a single patient and the observed data consist of n trajec-
tories of the form (Oti,Ati,Rti) for patients i = 1, . . . , n and
t = 1, 2. A dynamic treatment regime, denoted by d = (d1, d2),
is a sequence of treatment rules at each stage, that is, dt is a
deterministic function mapping each value of Ot to the domain
of At , that is, {−1, 1}. Corresponding to each d, we define its
value asV (d) = Ed(R1 + R2), which is the average total reward
if treatment assignments follow these rules at the two stages, that
is, At = dt (Ot ) for t = 1, 2. Thus, an optimal dynamic treat-
ment regime, denoted by d0 = (d10, d20), is a rule that maxi-
mizesV (d).
One commonly used method to estimate the optimal
dynamic treatment regime is Q-learning, which is a sequence
of regression models to be estimated backward for each
stage recursively. Specifically, in the Q-learning method (see
Chakraborty, Murphy, and Strecher 2010; Song et al. 2015), we
model the so-called Q-function at each stage as
Qt (Ht ,At ; θt ) = HTt βt + At (HTt ψt ), (1)
where Ht = (1,Ot ) takes values in Rpt . Among the parameters
of the above Q-function θt = (βTt ,ψTt )T , βt = (βt1, . . . , βt pt )T
reflects the main effect of the current state on the outcome,
while ψt = (ψt1, . . . , ψt pt )T reflects the interaction between
the current state and the treatment choice. It is worth men-
tioning that a more general model can be Qt (St ,Ht ,At; θt ) =
STt βt + At (HTt ψt ), for t = 1, 2, in which St and Ht can be dif-
ferent subsets of (1,Ot ). When Ht ’s dimension is not high, a
typical Q-learningmethod is to perform a sequence least-square
regression backward from the last stage. At the tth stage’s regres-
sion, the mean structure in the regression is the same as (1) but
the outcome variable is Rt if t = 2 and the summation of Rt and
predictedQt+1(Ht+1,A∗t+1; θ̂t+1) if t = 1, where θ̂t+1 is the esti-
mated coefficient for θt+1 and A∗t+1 = sign(HTt+1ψ̂t+1), that is,
the estimated optimal treatment that maximizes the Q-function
at the (t + 1)-stage.
In most of personalized medicine, Ht includes individual
genomics, baseline biomarkers, and intermediate outcomes,
so its dimension can be very high. Therefore, the standard Q-
learning proceduremay not be feasible due to high-dimensional
regression models. Furthermore, since most of Ht are not pre-
dictive of treatment effects, identifying those predictive covari-
ates and removing other noisy covariates from the Q-learning
regression will improve the estimation of the optimal dynamic
treatment regime. Therefore, we propose the following Q-
learning procedure with high-dimensional predictors by incor-
porating proper sparse penalization at each stage of Q-learning.
We allow that pt is much larger than the number of observa-
tions n, and further assume that majority of the true parameters
θt0 = (βTt0,ψTt0)T are exactly zero for t = 1, 2. The proposed Q-
learning procedure with high-dimensional predictors consists
of the following three steps when pt  n for t = 1, 2.
Step 1. We estimate the second-stage parameters by minimiz-









pλ2n (|β2 j|)+ pλ2n (|ψ2k|)
}





pλ2n (|β2 j|)+ pλ2n (|ψ2k|)
}
. (2)
In the above least-square estimation, Z2 =
(ZT21, . . . ,ZT2n)T is the n × 2p2 design matrix and
can be also denoted by Z2 = (H2,H2A2) with
H2 = (HT21, . . . ,HT2n)T being an n × p2 matrix, and
y2 = (Y21, . . . ,Y2n)T is the optimal potential reward in
the second stage. Additionally, we include two penal-
ization terms to achieve sparsity in the Q-function
estimation. Particularly, pλ2n (·) belongs to the class of
folded-concave penalty functions (Lv and Fan 2009),
and λ2n  0 is regularization parameters indexed by
sample size n. This class of penalties tends to give esti-
mators with three desired properties advocated by Fan
and Li (2001): unbiasedness, sparsity, and continuity.
The SCAD (Fan and Li 2001) and MCP (Zhang 2010)
with a  1 belong to this class of penalties, whose
derivatives of penalties are, respectively, given by
p′λ2n (β) = λ2n
{
I(β  λ2n)+ (aλ2n − β)+
(a − 1)λ2n I(β >λ2n)
}
,
t  0 for some a  2,
where often a = 3.7 is used, and p′λ2n (β) = (aλ2n −
β)+/a for t  0. We use this class of penalties to estab-
lish the oracle property of the estimators and to make
inference further in the first stage of Q-learning. We





T as the minimizer of the penal-





of β̂2 and ψ̂2 formed by all the nonzero components,
respectively.
Step 2. We obtain the first-stage individual pseudo-outcomes
ŷ1 with hard-threshold as
ŷ1 = R1 + H2,Mβ̂
(1)
2 +
∣∣H2,Iψ̂(1)2 ∣∣ · 1|H2,Iψ̂(1)2 |>2n , (3)
where H2,M and H2,I denote the submatrices of H2
formed by columns corresponding to the indexes of
the nonzero components of β̂2 and ψ̂2, respectively,
and |H2,Iψ̂
(1)
2 | · 1|H2,Iψ̂(1)2 |>2n is an n-dimensional vec-
tor with the ith entry |HT2i,Iψ̂
(1)
2 | · 1|HT2i,Iψ̂(1)2 |>2n . Here,
2n is a small constant depending on n. The purpose
of using the truncated pseudo-outcomes is to overcome
the difficulty of inference for the Q-learning due to the
nature of the nonregularity when P(HT2i,Iψ
(1)
20 = 0) > 0
(Chakraborty, Murphy, and Strecher 2010; Moodie and
Richardson 2010; Laber et al. 2014; Song et al. 2015).
In contrast, the pseudo-outcomes without truncation
in the standard Q-learning involves a nonsmooth func-
tion of ψ̂
(1)
2 , which will cause that the estimators of the
parameters in Step 3 is also a nonsmooth function of
ψ̂
(1)
2 . As a consequence, the asymptotic distribution of
estimated parameters is not always normal distribution.
Step 3. We estimate the first-stage parameters by minimizing









pλ1n (|β1 j|)+ pλ1n (|ψ1k|)
}





pλ1n (|β1 j|)+ pλ1n (|ψ1k|)
}
, (4)
where Z1 = (ZT11, . . . ,ZT1n)T is the n × 2p1 design
matrix and can be also denoted by Z1 = (H1,H1A1)
with H1 = (HT11, . . . ,HT1n)T is an n × p1 matrix, and
ŷ1 = (Ŷ11, . . . , Ŷ1n)T is the pseudo-outcomes from
Step 2. For simplicity, here we use the same penalty
functions pλ1n (·) given in (2), but we adopt the differ-
ent regularization parameters λ1n  0. Similar to the











1 are subvectors of β̂1 and ψ̂1 formed by all the
nonzero components, respectively.
There are two key features of our proposed Q-learning
with high-dimensional predictors which make the proposed
method different from the standard Q-learning method. First,
we include sparsity penalization in both stages to encourage that
the finalmodel leads to a sparse Q-functionwith only important
predictors in the function. The penalization also makes high-
dimensional regression feasible. Second, we introduce the trun-
cated pseudo-outcome in the first-stage regression. By trunca-
tion, we set the treatment effects to zeros only for those sub-
jects whose treatment effects are very small (< 2n) so the
induced bias is negligible. Furthermore, as will be shown in
the next section, this simple truncation will tackle the chal-
lenge of inference due to nonregularity in the presence of posi-
tive zero-treatment effect probabilities, which is well known in
the Q-learning inference literature (Chakraborty, Murphy, and
Strecher 2010; Moodie and Richardson 2010; Laber et al. 2014;
Song et al. 2015).
We call our approach high-dimensional Q-learning (HQ-
learning). The HQ-learning allows us to simultaneously esti-
mate the optimal dynamic treatment regimes and select the
important variables that truly contribute to the individual
reward at each stage.
3. Theoretical Properties
In this section, we provide theoretical justification of HQ-
learning. In particular, we show that under some regularity con-
ditions for the sparsity structure in the true Q-functions and the
choice of the penalties, the proposed method possesses the ora-
cle property of selecting important predictors with probability 1.
Furthermore, we obtain the asymptotic distribution of the esti-
mated dynamic treatment rules, which will be the key to estab-
lish a valid inference of the optimal value estimation to be given
in the next section. In our results, we allow that the dimension-
ality of the covariates is ultra-high in terms of the exponential
polynomial rate of the sample size. The latter is commonly seen
if individual omics data are used to determine dynamic treat-
ment regimes.
We first study the oracle properties of θ̂1 and θ̂2 and show
that they converge to the true parameters θ10 and θ20 in
probability. For the purpose of illustration, for t = 1, 2 we






T , where each component of β(1)t0 and ψ
(1)
t0 is
nonzero but β(2)t0 = 0 and ψ(2)t0 = 0, and we also denote
supp(θt0) =
{











j ∈ {1, . . . , pt} : ψt0, j = 0
}
.
We refer to the numbers of components of θ(1)10 and θ
(1)
20 as sn and
rn, respectively. We also refer to dtn = 2−1 min{|θt0, j| : θt0, j =
0} as half of the minimum signal for t = 1, 2. In addition, we
let λmin(·) and λmax(·) represent the smallest and largest eigen-
values of a symmetric matrix respectively. Let zt j denote the
jth column of Zt (t = 1, 2, and j = 1, . . . , 2pt ). Without loss
of generality, we assume that zt j has been standardized so that
E‖zt j‖2 =
√
n. Hereafter, for any random vectorsU andV with
E(U ) = E(V ) = 0, we denote UVT as the covariance matrix
of U and V . We also denote Pn f (x) = 1/n
∑n
i=1 f (xi) as the
empirical measure.
Since the estimation of θ2 is based on a penalized least-square
estimation with a nonconcave penalty, both weak oracle prop-
erty and oracle property of θ̂2 can be established under the fol-
lowing conditions.
(A1) For the covariance matrix Z2Z2 , λmin(Z2,(1)ZT2,(1) )  C1,
λmax(Z2,(1)ZT2,(1)
)  C2, trace(Z2,(1)ZT2,(1) ) = O(rn), and‖Z2,(2)ZT2,(1)‖∞ = O(rn).
(A2) The nonsparsity size rn = o(n) and the dimensionality














and λ2nκ20 = o(1), where κ20 = maxδ∈N20 κ(ρ; δ). Here,N20 = {δ ∈ Rrn : ‖δ− θ20‖∞  d2n}, and the function






t1<t2∈(|v j |−ε,|v j |+ε)
−ρ
′(t2)− ρ ′(t1)
t2 − t1 ,
with ‖v‖0 = q, and ρ(·) = λ−1pλ(·) for the regulariza-
tion parameter λ  0. We assume that pλ(·) satisfies
Condition 1 in Lv and Fan (2009).
(A3) Assume ε̃i = Y2i − HT2iβ20 − A2i(HT2iψ20). There exist















Moreover, maxni=1 E|ε̃i|3 = O(1).










Remark 1. For more remarks about Conditions A1 and A2
please refer to Fan and Lv (2011). ConditionA3 is used to bound
the deviation of the p-dimensional randomvectorZT2 Y2 from its
mean ZT2 θ20, which also holds if ε̃i is sub-Gaussian. Condition
A4 is related to the Lyapunov condition.
The following theorem gives the asymptotic property of θ̂2,
whose proof is similar to Fan and Lv (2011) so is skipped.






T of2(θ2), where θ̂
(1)
2 is the subvector of θ̂2
indexed by supp(θ20), such that
(i) θ̂
(2)
2 = 0 with probability tending to 1 as n → ∞;
(ii) ‖θ̂2 − θ20‖2 = OP(
√
rn/n);
(iii) If Condition A4 also holds and p′λ2n (d2n) =










) D−→ N(0, JD),
whereDn is a g × rn matrix such thatDnDTn → JD, JD is a
g × g symmetric positive definite matrix, and Z2,(1)ZT2,(1)
is the positive definite covariance matrix of Z2,(1).
Next, we study asymptotic properties of θ̂1. Assume that the
true model for the Q-function at the first stage is
y1 = Z1θ1 + ε, (6)
where y1 = (Y11, . . . ,Y1n)T = R1 + H2,Mβ(1)20 + |H2,Iψ(1)20 |
denote the n-dimensional potential rewards for the first stage,
and ε = (ε1, . . . , εn)T is an n-dimensional vector of noises. For
each subject i, we assume that Z1i is independent to εi. To study
the oracle property of θ̂1, we need the following assumptions.
















 C4; (9)∥∥Z1,(2)ZT2,(1)∥∥∞ = O(rn); (10)∥∥Z1,(2)ZT1,(1)∥∥∞ = O(sn). (11)
(B2) Assume 2n = n−ϑ for some constant ϑ satisfying that
rnn−1/2 = o(2n), and2n = O( rn√n ).
(B3) The nonsparsity size sn = o(n) and the dimensional-
ity satisfies log p1 = O(nς1 ) for some ς1 ∈ (0, 1/2).







log n} = o(λ1n), p′λ1n (d1n) = O(n−1/2),
and λ1nκ10 = o(1), where κ10 = maxδ∈N10 κ(ρ; δ),N10 = {δ ∈ Rsn : ‖δ− θ10‖∞  d1n} and κ(ρ; v) is
defined in Condition A2.
(B4) Assume that εi = Y1i − HT1iβ10 − A1i(HT1iψ10) satisfies
Equation (5) in ConditionA3 andmaxni=1 E|εi|3 = O(1).










Remark 2. ConditionB1 gives the usual constraints on the corre-
sponding covariancematrices. Condition B2 enables us to select
reasonable thresholds such that we still obtain correct asymp-
totic properties of θ̂1 despite that the thresholding introduces us
some biases. Condition B3 imposes constraints on the penalty
function in terms of the minimum signal d1n in order for the
estimators to entail the oracle properties. Conditions B4 and B5
are very similar to Conditions A3 and A4, respectively.






T of 1(θ1) such that θ̂
(2)
1 = 0 with proba-
bility tending to 1 as n → ∞ and ‖θ̂1 − θ10‖2 = OP(√sn/nϑ ),
where θ̂
(1)
1 is the subvector of θ̂1 indexed by supp(θ10).
We are going to establish the asymptotic distribution of θ̂1 in
next theorem.One difficulty is that the optimal pseudo-outcome
Y1 as well as its estimation Ŷ1, obtained by existingmethods such
as the standard two-stage Q-learning procedure, involve nons-
mooth function of ψ(1)20 and ψ̂
(1)
2 . Since θ̂1 is a function of Ŷ1, it
is also a nonsmooth function of ψ̂
(1)





1 − ψ(1)10 ) is not normal any more
if P(HT2,Iψ
(1)
20 = 0) > 0, that is, there are nonignorable nonre-
spondents in Stage 2. However, through the hard-threshold,
our estimation automatically removes the effects of these non-
respondents in the inference with a price of inducing bias due
to the truncation. Therefore, the asymptotic distribution of the
estimators entails a careful control of this bias in the proof. The
following theorem gives the asymptotic normality.
Theorem 3. Under the conditions of Theorem 2 and Condition
B5, if p′λ1n (d1n) = o(s
−1/2
n n−1/2), sn = o(n1/3), and rn = o(n1/4),
for a g × sn matrix An satisfying AnATn → JA, and JA is a g × g









1 − θ(1)10 +−1Z1,(1)ZT1,(1)b
) D−→ N(0, cov),




























where F1(θ10) = 2−1∇θ1Q1(Z1; θ10)(Y1 − Q1(Z1; θ10)), F2(θ20)
= −1Z2,(1)ZT2,(1)2
−1∇θ2Q2(Z2; θ20)(Y2 − Q2(Z2; θ20)).
Remark 3. Although b will go to 0 as n goes to infinity, it is non-
negligible after multiplied by a factor of
√





∣∣HT2,Iψ(1)20 ∣∣·1|HT2,Iψ̂(1)2 |2n1|HT2,Iψ(1)20 |>2n)=OP(n1/2−ϑ)
and ϑ < 1/2.We refer to b here as the bias induced by the trun-
cation in the pseudo-outcomes of the first stage.
Theorem 3 shows that the linear combination Anθ̂
(1)
1 is
asymptotically normal for any finite g as the length of θ̂
(1)
1
depends on n. This is very essential to construct the confidence
interval for the optimal value function of the first stage.
4. Optimal Value Estimation
In the dynamic treatment regimes, one important goal is to eval-
uate the value function of the obtained treatment regimes, which
is characterized as the average reward if the estimated treat-
ment rule would be applied to the same population in future.
Simple algebra gives that under the proposed model, the value
function associated with the true optimal treatment regimes is
E[Q∗1(Z1; θ10)], where






Therefore, one natural estimator of the value function for the
estimated optimal dynamic treatment regime in our approach
is





The following theorem gives the asymptotic distribution of this
estimator.
Theorem 4. In addition to the conditions of Theorem 3, we fur-
ther assume that sn = o(n(v−1/4)), 1n = O( 1nγ ) for some con-




PnQ̂∗1(Z1; θ1)− E(Q∗1(Z1; θ10))+ b







b = E(∣∣HT1,Iψ(1)10 ∣∣ · 1{|HT1,Iψ̂(1)1 |1n} · 1{|HT1,Iψ(1)10 |>1n}),
and





In addition, b, F1(θ10), F2(θ20), and Z̄2,(1) are given in Theorem
3.
Remark 4. Aswe shown in Remark 3, b is also not ignorable after√
n-scale in Theorem 4, which is another part of bias induced
by the truncation in the estimation of value function (12). Con-
sequently, a better estimator of the value function for the esti-
mated optimal dynamic treatment regime is the estimator of
(12) adjusted by the bias given in Theorem 4.
Theorem 4 shows that the average of the optimal value func-
tion estimation PnQ̂∗1(Z1; θ1) is asymptotically normal under
some mild conditions. Following Theorem 4, we can construct
asymptotically valid confidence intervals by correcting the bias
for the optimal value function of the first stage.
To construct the confidence interval of E(Q∗1(Z1; θ10)), we
need first to estimate the variance σ 2U and the bias Bias = b+
E(Z̄T1,(1))−1Z1,(1)ZT1,(1)b. The estimated bias is
B̂ias = b̂+ (Pn[̂Z̄1,(1)])T (Pn[Z1,(1)ZT1,(1)])−1̂b,
where
b̂ = Pn




∣∣HT2,Iψ̂(1)2 ∣∣ · 1|HT2,Iψ̂(1)2 |2n1|HT2,Iψ̂(1)2 |>2n),
and




The estimated variance is



















])−1∇θ2Q2(Z2; θ̂2)(Y2 − Q2(Z2; θ̂2)),
and




Given the estimated variance σ̂ 2U and the estimated bias B̂ias, the
100 × (1 − α)% confidence interval is(










where zα/2 satisfies P(T  zα/2) = α/2 with T ∼ N(0, 1).
Remark 5. According to Condition B2 and the assumptions
in Theorem 3, 2n = O( rn√n ), 2n = n−ϑ with 2n = o(2n),
and rn = o(n1/4). In addition, according to the assumptions
of Theorem 4, it requires 1n = O( snnϑ ), 1n = O(n−γ ) with
1n = o(1n), and sn = o(n(v−1/4)). These asymptotic rates of
tuning parameters can serve as a general guide of how to
select (2n,2n) and (1n,1n). Thus, we can choose 2n =
C21n−τ21 ,2n = C22n−τ22 , and 1n = C11n−τ11 ,1n = C12n−τ12 ,
where Ci j and τi j for i, j = 1, 2 are positive constants with
the constraint of τ11 < τ12  τ21 < τ22  1/2. In our simu-
lation studies and real data analysis, for simplicity, we fix
τ11 = 1/3, τ12 = 2/5, τ21 = 2/5, and τ22 = 1/2. It remains to
choose the tuning constants Ci j, i, j = 1, 2. To this end, we
use bootstrapping method by constructing bootstrapped confi-
dence intervals for each choice of tuning parameter value, then
select the best coverage rates (Altman and Leger 1994). Because
the bootstrap is time-consuming especially for the large-scale
simulation studies, we recommend to choose (C21,C22) and
(C11,C12) separately in different bootstrap procedures instead of
choosing them simultaneously. That is, we first choose the tun-
ing parameters C21 and C22 that give the best average coverage
rates of coefficients related to the selected variables in Stage 1
through bootstrapping among a candidate set. By fixingC22 and
C21, we next chooseC11 andC12 that give the best coverage rates
for estimating value function through another bootstrap proce-
dure among a given candidate set. Finally, to choose a penalty
(pλ2n (·) or pλ1n (·)) in our HQ-learning procedure, we use the
SCADpenalty (Fan and Li 2001) in the following simulation and
real data analysis, in which the regularization parameter (λ2n or
λ1n) are selected by Bayesian information criterion (BIC).
5. Simulation Studies
We conduct simulation studies to assess the performance of
penalization and truncation of the HQ-learning in this section,
which are exactly the two key features of our proposed method.
5.1. Simulation Settings
Wefirst simulatem1 baseline covariatesO1 = (O11, . . . ,O1m1 )T
and the treatment A1 for the first stage. We further simulate
m2 baseline covariates O2 = (O21, . . . ,O2m2 )T and the treat-
ment A2 in the second stage. The binary treatments At ’s are
generated according to P(At = 1) = 1 − P(At = −1) = π for
t = 1, 2.Without loss of generality, we assume thatO21 is related
to O11 and is generated as follows,
O21 = δ1O11 + δ2A1 + e
with e ∼ N(0, σ 22 ), and O11, . . . ,O1m1 , O22, . . . ,O2m2 are gen-
erated independently from N(0, 1).
We set R1 = 0. To consider the model sparsity, we
treat O12, . . . ,O1m1 , O21, . . . ,O2m2 as noise covariates, and
O22A2, . . . ,O2m2A2 as noise interactions with A2 when simu-
lating R2. Moreover, to evaluate the performance of the variable
selections of both stages and statistical inference of the optimal
value function for the first stage in the presence of nonregularity,
we simulate R2 from the following model:
R2 = γ1 + γ2O11 + γ3A1 + γ4O11A1
+ (γ5O11 + γ6O21 + γ7A1)A2 · 1{|HT2,Iψ(1)20 |>α0} + ε, (13)
where ε ∼ N(0, σ 21 ),HT2,Iψ(1)20 = γ5O11 + γ6O21 + γ7A1, and α0
is a small number used to control the degree of nonregularity,
which is defined as the proportion of those subjects without
treatment effects among all the subjects.
Based on the sparsity model (13), the Q-function and the
optimal Q-function of Stage 2 are, respectively,
Q2(O1,O2,A1,A2) = γ1 + γ2O11 + γ3A1 + γ4O11A1
+ (γ5O11 + γ6O21 + γ7A1)A2
· 1{|HT2,Iψ(1)20 |>α0},
Q∗2(O1,O2,A1,A2) = γ1 + γ2O11 + γ3A1 + γ4O11A1
+ |γ5O11 + γ6O21 + γ7A1|
· 1{|HT2,Iψ(1)20 |>α0}.
Note that a linear model with covariate O1,O2, A1, and A2 is
fitted for the Q function in the second stage, which is misspeci-
fied unless α0 = 0 or the degree of nonregularity is 100% in this
simulation. Following this optimal Q-function at Stage 2, the Q-
function at Stage 1 is
Q1(O1,A1)
= γ1 + γ2O11 + γ3A1 + γ4O11A1
+E(|γ5O11 + γ6O21 + γ7A1| · 1{|HT2,Iψ(1)20 |>α0}|O1,A1)
= γ1 + γ2O11 + γ3A1 + γ4O11A1














Table . Simulation results on variable selection of the second stage for n = 200.
Setting  Setting  Setting 
(p1, p2) NR FN FP FN FP FN FP
(, )  . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
 . . . . . .
(, )  . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
 . . . . . .
(, ) . . . . . . .
. . . . . . .
. . . . . . .
. . . . . . .
 . . . . . .





















where μ = (γ5O11 + γ7A1)/γ6 + (δ1O11 + δ2A1), γ ′6 =
α0/|γ6|, and (·) is the cumulative distribution function
of standard normal. Note that a linear model is also used to fit
the Q-function Q1(O1,A1) in the first stage, which is misspeci-
fied unless μ = 0 or the degree of nonregularity is 100% in this
simulation.
We chooseπ = 0.5, σ1 = σ2 = 1, and consider the following
three settings with different levels of model misspecification:
 Setting 1: γ5 = γ7 = δ1 = δ2 = 0, and all other γ ’s equal 1;
 Setting 2: γ6 = 0, δ1 = δ2 = 0.5, and all other γ ’s equal 1;
 Setting 3: γ1 = γ2 = γ3 = γ4 = 0.5, γ5 = γ6 = γ7 = 0.8,
and δ1 = δ2 = 0.8.
The model is correctly specified under Setting 1, while the
level of model misspecification under Setting 3 is higher than
that under Setting 2 since our HQ-learning uses a linear model
to fit the Q-functionQ1(O1,A1) in the first stage. To choose the
tuning parameters, we set C11 ∈ {1, . . . , 10}, C12 ∈ {1, . . . , 6},
C21 ∈ {5, . . . , 15}, and C22 ∈ {1, . . . , 10}, then we try different
combinations ofC21 andC22 in the first bootstrap procedure, and
different combinations ofC11 andC12 in the next bootstrap pro-
cedure, respectively. All results are based on 5000 replications in
the simulation studies.
5.2. ComparisonWith HQ-learningWithout Truncation
As mentioned previously, our HQ-learning used a truncated
pseudo-outcome in Step 2 of the first-stage regression to ease
the inference in the presence of nonregularity. For the pur-
pose of comparison, we consider an alternative procedure,
which used the pseudo-outcome without truncation in Step
2 of the first-stage regression. We call the alternative proce-
dure HQ-learning without truncation, and compare it with
our HQ-learning in the simulation studies. The simulation
study compares the competing estimators on a variety of set-
tings under different degrees of nonregularity. To control the
degrees of nonregularity, we choose α0 = 0, 0.32, 0.68, 1.15,
and 5 in Setting 1, α0 = 0, 0.52, 1.05, 1.7, and 5 in Setting 2,
and α0 = 0, 0.7625, 1.58, 2.588, and 10 in Setting 3, which
correspond to the proportions of nonregularity 0%, 25%, 50%,
75%, and 100%, respectively. We consider sample size n = 200,
and setm1 = m2 = 25, 80, and 200, then the dimensions of the
covariates are 51, 161, and 401 for the first state, and 127, 402,
and 1002 for the second stage, respectively. Additional results
for n = 400 and 600 are provided in the supplementarymaterial.
We not only evaluate the performance of the variable selections
of both stages, but also consider estimations and inference for
ψ11, ψ12, and the optimal value function for the first stage in the
presence of nonregularity. The population parameter ψ11, ψ12
and the true value function are estimated based onMonte Carlo
procedure by choosing linear model as the working model.
Tables 1 and 2 summarize variable selection results for
estimated optimal Q-functions of both second and first stages,
respectively. Specifically, we report the false negative (FN) rate
(the percentage of important variables that are missed) and false
positive (FP) rate (the percentage of unimportant variables that
are selected) of the 5000 replications. Based on the Q-function
Q1(O1,A1) given in Section 5.1, we clearly know which vari-
ables are important and which are not although the models
are misspecified under settings 2 and 3. The results of variable
selection of HQ-learning are identical with that of HQ-learning
without truncation in Stage 2 because both methods are exactly
the same for Step 1. We can easily see from Table 1 that FN and
FP rates are very small in most cases, which shows that both
methods can identify the important predictors and remove noise
covariates properly for Stage 2 in the estimation of the optimal
dynamic treatment regime when the dimensional covariates
is very high. However, the FN rates become higher when the
degree of nonregularity is 100% for all three settings as well as
when the degree of nonregularity is higher (75%, even for 50%)
for Setting 3. This is not surprising as HT2,Iψ
(1)
20 = 0 for all sub-
jects if the degree of nonregularity is 100%, which is equivalent
that γ5 = γ6 = γ7 = 0 in Stage 2. At the same time,HT2,Iψ(1)20 = 0
for most of subjects if the degree of nonregularity is 75%. As
a result, the variables attached to these coefficients (especially
for γ6) will be missed during selecting variables. Table 2 shows
that the results of variable selection for HQ-learning and
HQ-learning without truncation are very similar for all settings,
and both methods have very good performance on variable
selection in Stage 1 whatever the degree of nonregularity is in
Table . Simulation results on variable selection via HQ-learning and HQ-learning without truncation of the first stage for n = 200.
Setting  Setting  Setting 
FN FP FN FP FN FP
(p1, p2) NR HQLN HQL HQLN HQL HQLN HQL HQLN HQL HQLN HQL HQLN HQL
(, )  . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
 . . . . . . . . . . . .
(, )  . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
 . . . . . . . . . . . .
(, )  . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
 . . . . . . . . . . . .
NOTES: FN: percentage of important variables that are missed. FP: percentage of unimportant variables that are selected. NR: the degree of nonregularity. HQLN: HQ-
learning without truncation. HQL: HQ-learning.
Stage 2. Combining Table 1 and Table 2, we conclude that the
truncated pseudo-outcome used in the first-stage regression
did not deteriorate variable selection performance for the
estimation of the optimal dynamic treatment regime, which is
consistent with the theoretical observations in terms of variable
selection of our HQ-learning.
Tables 3–5 list the biases of the estimates ofψ11, ψ12, the opti-
mal value function for the first stage as well as the empirical cov-
erage probability of 95% nominal percentile confidence interval
for ψ11, ψ12, and the optimal value function of Stage 1. From
the results we can see that although our HQ-learning induced
some biases due to the truncation, after carefully adjusting for
the biases, the biases of HQ-learning are comparable with that
ofHQ-learningwithout truncation. It should be pointed out that
the bias of HQ-learning without truncation becomes very large
when the degree of nonregularity is 100% formost cases, but the
HQ-learning still has reasonable bias under these cases. More-
over, the standard errors of the estimates of both HQ-learning
and HQ-learning without truncation are also reasonable and
comparable.
In settings 1 and 2, the coverage rates of ψ11 and ψ12 of HQ-
learning are a bit closer to the nominal percentile 95% than that
of HQ-learning without truncation, but the coverage rates of
both methods are basically comparable in most cases. In Set-
ting 3, the coverages ofψ11 andψ12 for both methods are a little
low except the case of 100% nonregularity, but HQ-learning still
has better coverages than HQ-learning without truncation for
some cases. Most likely, the problem of model misspecification
becomes more severe for Setting 3, so the performance of vari-
able selection is not perfect (see Tables 1 and 2), however, the
Q-function Q1(O1,A1) in the first stage is exactly linear when
the degree of nonregularity is 100%, which was correctly speci-
fied for the estimation of the optimal dynamic treatment regime
in the first stage.
For the coverage of the optimal value function, the coverage
rates of HQ-learning are higher and closer to 95% than that
of HQ-learning without truncation for all three settings when
the degree of nonregularity is 100%. For the other degrees of
nonregularity, the coverages of the optimal value function for
HQ-learning are slightly closer to the nominal level than that of
Table . Summary statistics and coverage rates of % nominal percentile forψ11 ,ψ12 , and the optimal value function of the first stage for n = 200 (Setting ).
ψ11 ψ12 Q
Bias SE CI Bias SE CI Bias SE CI
(p1, p2) NR HQLN HQL HQLN HQL HQLN HQL HQLN HQL HQLN HQL HQLN HQL HQLN HQL HQLN HQL HQLN HQL
(, )  −. −. . . . . −. −. . . . . . −. . . . .
. −. −. . . . . −. −. . . . . . . . . . .
. −. −. . . . . −. −. . . . . . . . . . .
. −. −. . . . . −. −. . . . . . . . . . .
 −. −. . . . . −. −. . . . . . . . . . .
(, )  −. −. . . . . −. −. . . . . . . . . . .
. −. −. . . . . −. −. . . . . . . . . . .
. −. −. . . . . −. −. . . . . . . . . . .
. −. −. . . . . −. −. . . . . . . . . . .
 −. −. . . . . −. −. . . . . . . . . . .
(, )  . . . . . . −. −. . . . . . . . . . .
. . . . . . . −. −. . . . . . . . . . .
. . . . . . . −. −. . . . . . . . . . .
. . . . . . . −. −. . . . . . . . . . .
 −. −. . . . . −. −. . . . . . . . . . .
NOTES: NR: the degree of nonregularity. HQLN: HQ-learning without truncation. HQL: HQ-learning.
Table . Summary statistics and coverage rates of % nominal percentile forψ11 ,ψ12 , and the optimal value function of the first stage for n = 200 (Setting ).
ψ11 ψ12 Q
Bias SE CI Bias SE CI Bias SE CI
(p1, p2) NR HQLN HQL HQLN HQL HQLN HQL HQLN HQL HQLN HQL HQLN HQL HQLN HQL HQLN HQL HQLN HQL
(, )  −. −. . . . . −. −. . . . . . −. . . . .
. −. −. . . . . −. . . . . . . −. . . . .
. −. −. . . . . −. . . . . . . −. . . . .
. −. −. . . . . −. −. . . . . . −. . . . .
 −. −. . . . . −. −. . . . . . . . . . .
(, )  −. −. . . . . −. −. . . . . . . . . . .
. −. −. . . . . −. −. . . . . . . . . . .
. −. −. . . . . −. −. . . . . . −. . . . .
. −. −. . . . . −. −. . . . . . . . . . .
 −. −. . . . . −. −. . . . . . . . . . .
(, )  −. −. . . . . −. −. . . . . . −. . . . .
. −. −. . . . . −. −. . . . . . . . . . .
. −. . . . . . −. −. . . . . . . . . . .
. . . . . . . −. −. . . . . . . . . . .
 −. −. . . . . −. −. . . . . . . . . . .
NOTES: NR: the degree of nonregularity. HQLN: HQ-learning without truncation. HQL: HQ-learning.
HQ-learning without truncation for most of cases in Setting 1,
and the coverages of the optimal value function for both meth-
ods are comparable in settings 2 and 3. Again, due to model
misspecification, the coverages of the optimal value function for
bothHQ-learning andHQ-learning without truncation become
low in Setting 3, especially for HQ-learning without truncation
with 100%degree of nonregularity. Besides, for ourHQ-learning
in Setting 3, the results under 100% degree of nonregularity are
better than that of 75% degree of nonregularity (even others)
based on the coverages ofψ11,ψ12, and value function (Table 5)
as well as the values of FN in the first stage (Table 2), which is
also because the model was correctly specified under this case.
In conclusion, by truncation, our HQ-learning can improve
the coverage rates via bias adjustment in the presence of non-
regularity in most of cases, especially when the underlingmodel
is correctly specified and/or the degree of nonregularity is very
high. Furthermore, the running time of the HQ-learning is
acceptable. For example, for the case of n = 200, (p1, p2) =
(401, 1002) at the degree of nonregularity 50%, the simulation
with 5000 replications took 5.68 hr to run on a computer with a
2.3GHz dual core processor.
5.3. ComparisonWith the Nonpenalized Q-learning
In this subsection, we compare our HQ-learning with the
standard Q-learning (without penalty and without truncation)
and the soft-threshold Q-learning (Chakraborty, Murphy, and
Strecher 2010). The simulation setting is the same as in Section
5.2, except thatm1 = m2 = 15 and the dimensions of the covari-
ates are 31 and 77 for each stage, respectively, since the non-
penalized methods are not applicable for a higher dimension.
Moreover, for the standardQ-learning and the soft-thresholdQ-
learning, as the confidence interval constructions are not based
on explicit formulas, we consider percentile and hybrid boot-
strap confidence intervals similar to Chakraborty, Murphy, and
Strecher (2010).
The simulation results are presented in Figures 1 and 2, where
we report the mean square errors (MSEs) and the coverage rates
Table . Summary statistics and coverage rates of % nominal percentile forψ11 ,ψ12 , and the optimal value function of the first stage for n = 200 (Setting ).
ψ11 ψ12 Q
Bias SE CI Bias SE CI Bias SE CI
(p1, p2) NR HQLN HQL HQLN HQL HQLN HQL HQLN HQL HQLN HQL HQLN HQL HQLN HQL HQLN HQL HQLN HQL
(, )  −. −. . . . . −. −. . . . . −. −. . . . .
. −. −. . . . . −. −. . . . . −. −. . . . .
. −. −. . . . . −. −. . . . . −. −. . . . .
. −. −. . . . . −. −. . . . . −. −. . . . .
 −. −. . . . . −. −. . . . . . . . . . .
(, )  −. −. . . . . −. −. . . . . −. −. . . . .
. −. −. . . . . −. −. . . . . −. −. . . . .
. −. −. . . . . −. −. . . . . −. −. . . . .
. −. −. . . . . −. −. . . . . −. −. . . . .
 −. −. . . . . −. −. . . . . . . . . . .
(, )  −. −. . . . . −. −. . . . . −. −. . . . .
. −. −. . . . . −. −. . . . . −. −. . . . .
. −. −. . . . . −. −. . . . . −. −. . . . .
. −. −. . . . . −. −. . . . . −. −. . . . .
 −. −. . . . . −. −. . . . . . −. . . . .


























































































































































































Figure . MSE of the estimates of ψ11 , ψ12 , and the optimal value function for three settings: Setting  (first row), Setting  (second row), and Setting  (third row). HQL:
HQ-learning. SDQL: the standard Q-learning. softQL: the soft-threshold Q-learning.
of ψ11, ψ12, and the optimal value function for the first stage. In
settings 1 and 2, we can see that our HQ-learning has better per-
formance, especially for the inference of ψ11 and ψ12, than the
other two nonpenalized methods, from the points of produc-
ing smaller MSEs and better coverage rates of 95% confidence
intervals. For the standard Q-learning and the soft-threshold
Q-learning, although the coverage rates of the hybrid bootstrap
confidence intervals for the optimal value function are reason-
able, the results forMSEs and the coverage rates of the percentile
bootstrap confidence intervals become worse when the degree
of nonregularity increases. The HQ-learning does not perform
very well in Setting 3, because the performance of variable selec-
tion is heavily affected by model misspecification. In contrast,
the nonpenalizedmethods are nearly not affected bymodelmis-
specification, but they generally fail without variable selection
when the dimension is high.
6. Application to STAR*D Study
6.1. Background
Sequenced Treatment Alternatives to Relieve Depression
(STAR*D) is a multisite, sequentially randomized study that
aims to explore dynamically which is the most effective treat-
ment plan for each patient with major depressive disorder
(MDD) (Fava et al. 2003; Rush et al. 2004). This study initially
recruited a total of 4041 patients with nonpsychotic MDD and
those who have adequate clinical responses after each treatment
level will exempt from future randomization for the next treat-
ment level and enter the 12-month naturalistic follow-up phase.
For each treatment level, protocol medication clinic visits of the
participants without a satisfactory clinical outcome are required
at weeks 0, 2, 4, 6, 9, and 12.
At level 1, all 4041 participants were treated with citalopram
(CIT) and those who without a satisfactory clinical outcome to
CIT are eligible to enter treatment level 2. At level 2, patients
were randomly assigned to one of seven treatment options
including four switch options (venlafaxine (VEN), sertraline
(SER), bupropion (BUP), and cognitive therapy (CT)) and three
augment options (augmenting CIT with CT, BUP, or buspirone
(BUS)). Patients who were assigned to CT or CT+CIT in level 2
are eligible for a supplementary level treatment (level 2A) if they
did not have a satisfactory response in level 2 and will further
be treated with VEN or BUP in level 2A. At level 3, patients
without a satisfactory response to level 2 or level 2A would
continue to be randomly assigned to one of four treatments:
mirtazapine (MIRT), nortriptyline (NTP), and augmentation
their previous treatment with either lithium (Li) or thyroid
hormone (THY). Patients who did not respond satisfactorily




















































































































































































































Figure . Coverage rates of % confidence intervals forψ11 ,ψ12 , and the optimal value function for three settings: Setting  (first row), Setting  (second row), and Setting
 (third row). HQL: HQ-learning. SDQL.PB: the standard Q-learning with percentile bootstrap. SDQL.HB: the standard Q-learning with hybrid bootstrap. softQL.PB: the soft-
threshold Q-learning with percentile bootstrap. softQL.HB: the soft-threshold Q-learning with hybrid bootstrap.
two options: tranylcypromine (TCP) or MIRT+VEN. For
more details of the STAR*D study, see Fava et al. (2003) and
Rush et al. (2004).
6.2. Data Analysis
In our data analysis, we use a subset of patients from level 2
and level 3 of the STAR*D data to illustrate how HQ-learning
can be used to simultaneously estimate an optimal dynamic
treatment regime and select the important variables in the pres-
ence of nonregularity as well as high-dimensional covariates.
We refer to level 2 and level 3 of the trial as stages 1 and 2,
respectively. We will not consider treatments CT and CT+CIT
in our study because patients received treatment CT or CT+CIT
in level 2 moved to level 2A. Since our HQ-learning assumes a
dichotomized treatment design at each stage, we combine the
rest of five treatment options into two treatments in level 2 and
combine four treatments into two treatments in level 3. Specif-
ically, let the first-stage treatment A1 = 1 if level 2 treatment
belongs to switch options (VEN, SER, and BUP) and A1 = −1
if it belongs to augment options (CIT+BUP and CIT+BUS). For
level 3, let the second-stage A2 = 1 if the treatment is MIRT
or NTP and A2 = −1 if it is the previous treatment plus Li or
THY. To access the performance of variable selection and value
estimation of the proposed procedure in the high-dimensional
case, we collected 212 covariates in total which come from the
baseline and intermediate levels in this study. For treatment
regime at level 2, 206 of 212 covariates that were collected
before giving treatment at level 2, the treatment A1, as well
as all the interactions between 206 covariates and A1 were
considered to fit the penalized regression model, in which the
dimensionality is 413. In the penalized regression model of
level 3, all 212 covariates, the treatments A1 and A2, as well
as all the 206 interactions with A1 in level 2 were treated as
the main predictors, and their interactions with A2 were also
included in the model. The maximum dimensionality involved
in the model of level 3 is 837, which is much greater than
the sample size involved in the following analysis. Since the
severity of depression was measured by Quick Inventory of
Depressive Symptomatology-Clinician (QIDS-C16), where
higher values of QIDS-C16 score correspond to more severe
negative symptoms, we use the negative QIDS-C16 score as the
rewards right after the treatment at each level such that higher
values correspond to better clinical rewards. By removing the
patients whose information relative to any one of 212 covariates
is missing, only a subset containing 261 patients with complete
information remained in the final data analysis. Of the total
261 patients, 164 were assigned switch treatments (A1 = 1)
Table . Coefficient estimates of the selected variables as well as their standard errors and % confidence intervals for HQ-learning.
Variable Estimate SE % CI
Level  In protocol eligibility form at baseline
Fatigue or loss energy (DSMLE) − . . (−., .)
In clinic visit clinical record form at baseline
QIDS-C beginning score (QCBEG-) − . . (−., .)
QIDS-C current score (QCCUR-) − . . (−., .)
In clinic visit clinical record form at Level 
QIDS-C percent improvement (QCIMP-) . . (−., .)
In clinic visit clinical record form at Level 
QIDS-C percent improvement (QCIMP-) . . (−., .)
CGII score (CGI-I-) − . . (−., .)
In psychiatric diagnostic screening questionnaire form at baseline
TE Avoid activities remind of trauma (TERMD) − . . (−., .)
The interaction between “EMWorry about embarrassing self”
and A2 (EMWRY*A2) − . . (−., .)
The interaction between “Worry daily”and A2 (WYDLY*A2) . . (−., .)
In cumulative illness rating scale form at baseline
The interaction between “Upper GI”and A2 (UGI*A2) − . . (−., .)
Level  In cumulative illness rating scale form at baseline
Upper GI (UGI) . . (., .)
In protocol eligibility form at baseline
Highest degree received (DEGREE) . . (., .)
Fatigue or loss energy (DSMLE) − . . (−.,−.)
In clinic visit clinical record form at baseline
QIDS-C beginning score (QCBEG-) − . . (−.,−.)
QIDS-C current score (QCCUR-) − . . (−.,−.)
In clinic visit clinical record form at Level 
QIDS-C percent improvement (QCIMP-) . . (−., .)
In psychiatric diagnostic screening questionnaire form at baseline
Did you get less joy or pleasure from almost all of the things
you normally enjoy during the past two weeks? (JOYW) − . . (−.,−.)
The interaction between “TE Avoid activities remind of trauma”
and A1 (TERMD*A1) − . . (−.,−.)
Value function − . . (−.,−.)
and 97 were assigned augment treatments (A1 = −1) at level
2, and 158 were assigned switch treatments MIRT or NTP
(A2 = 1) and 103 were assigned the previous treatment plus
Li or THY (A2 = −1) at level 3. In this data analysis, we set
C11 ∈ {1, . . . , 15}, C12 ∈ {1, . . . , 10}, C21 ∈ {1, . . . , 25}, and
C22 ∈ {1, . . . , 10} to choose tuning parameters 1n,1n, 2n,
and2n by using bootstrap procedure mentioned above.
Our HQ-learning selected ten and eight variables for levels
3 and 2, respectively. Table 6 lists all the selected variables, their
coefficient estimates, standard errors of these estimates, and 95%
confidence intervals for each stage. Based on these 95% confi-
dence intervals, none of the selected variables at level 3 have sig-
nificant effect on the clinical outcome, while all eight selected
variables at level 2 have strong effect on the pseudo-outcome.
This shows that no significant level 3 treatment effect was found
at Stage 2, which further indicates possible existence of nonreg-
ularity. In particular, we found significant level 2 treatment effect
(TERMD*A1) on the pseudo-outcome. We thus summarize the
estimated optimal rule based onHQ-learning as follows. At level
3, there is no difference in switching MIRT and NTP or contin-
uing the previous treatment plus Li or THY. If a patient tried
to avoid activities, places, or people that reminded him/her of
a traumatic event (i.e., TERMD = 1) during the past 2 weeks
before the patient was enrolled in the study, and remained unsat-
isfactory in level 1, augment treatment (CIT+BUP or CIT+BUS)
is a better option for level 2 treatment when compared to switch
option (VEN, SER, or BUP).We also list the value estimation, its
standard error, and the corresponding 95% confidence interval
in Table 6.
To further examine the merits of our HQ-learning, we
compared it with HQ-learning without truncation, the standard
Q-learning, and the soft-threshold Q-learning (Chakraborty,
Murphy, and Strecher 2010). With the same dataset, HQ-
learning without truncation selected the same variables for each
stage as HQ-learning. By truncation, our HQ-learning got a
smaller standard error for the value estimation, as a result, the
length of the confidence interval becomes shorter. It is very
likely that this simple truncation reduced the difficulty of infer-
ence for the Q-learning due to nonregularity in the data analysis
by simultaneously adjusting for bias induced during truncation.
Because both the standard Q-learning and the soft-threshold
Q-learning failed in handling the high dimensionality of the
dataset, we first applied principal components analysis to each
stage and chose age, gender, and the top 15 principal component
scores as the covariates of interest. Based on these covariates of
interest as well as their interactions with treatment A1 and/or
A2 (the dimensionalities of Stage 1 and Stage 2 are 35 and 71,
respectively), we compared HQ-learning, HQ-learning without
truncation, the standard Q-learning, and the soft-threshold
Q-learning. Figure 3 shows that the widths of the 95% confi-
dence intervals of HQ-learning are obviously shorter than that
of the nonpenalized Q-learning for all the components selected
by HQ-learning. Besides, both the standard Q-learning and
the soft-threshold Q-learning missed the ninth component
and the significant level 2 treatment effect (Component 1*A1)
on the pseudo-outcome. All these results indicate that our

















































































































































































































Component 1 * A1
Figure . Width of % confidence intervals of HQ-learning (HQL), HQ-learning without truncation (HQLN), the standard Q-learning with percentile bootstrap (SDQL.PB)
and with hybrid bootstrap (SDQL.HB), and the soft-threshold Q-learning with percentile bootstrap (softQL.PB) and with hybrid bootstrap (softQL.HB) for the components
selected by HQ-learning at level .
7. Discussion
In this article, we proposed a high-dimensional Q-learning pro-
cedure to estimate optimal dynamic treatment regimes when
the number of covariates involved in each stage is huge. To
reduce the effect of nonregularity on the statistical inference of
Q-learning, we removed the treatment effects for those subjects
with very small treatment effects by using truncated pseudo-
outcome in the first-stage penalized regression. Although the
truncation induced some bias during the inference, the asymp-
totic properties for the parameter estimators as well as the
estimated optimal value function were established by adjusting
for the bias carefully. The simulation studies and real data anal-
ysis showed that our HQ-learning simultaneously estimated the
optimal dynamic treatment regimes and selected the important
variables very well in the presence of high-dimensional case and
nonregularity. While the inference of the HQ-learning without
truncation was affected by the nonregularity, in particular, the
bias of the estimates became large and the coverage rates of the
confidence intervals for the parameters and the optimal value
function were low when the degree of nonregularity is very high
(e.g., 100%).
We note that the penalized Q-learning of Song et al. (2015)
also minimized a penalized objective function in Step 1 of the
Q-learning procedure, which aimed to handle the problem
of nonregularity by using penalization to shrink some of
individual-level treatment effects to zeros. While our HQ-
learning used penalization at each stage to shrink some of
regression coefficients to zeros to select the important variables
that truly contribute to the individual reward in the face of
a large number of covariates. It is worthwhile yet beyond the
scope of the current article to combine these two kinds of penal-
izations to simultaneously perform individual selection and
variable selection in high-dimensional Q-learning for dynamic
treatment regimes.
We use the linear model as the working model for each
stage of our HQ-learning. Although the linearity may not hold
for Q-function, linear models are also most commonly used
working models to help understand the treatment heterogene-
ity among patients. Such models are particularly useful for
high-dimensional settings when variable selection is necessary.
Actually, for the dynamic treatment regimes, even when the
dimension is low, linear models are widely used in each of
stage for many methods including the standard Q-learning, the
soft-threshold method proposed in Chakraborty, Murphy, and
Strecher (2010). Furthermore, according to our simulation stud-
ies, the performance of the proposedmethod remains good even
if the linearity assumption does not hold for the trueQ-function.
Nevertheless a more flexible model such as semiparametric or
nonparametric models will be a better alternative in real data
analysis. It is of great interest to investigate Q-learning proce-
dures for dynamic treatment regimes with high-dimensional
variables undermore flexiblemodels.We shall leave this promis-
ing question for future work.
This article only focuses on the two-stage randomized trial,
but the HQ-learning can be generalized to the case of multiple
stages. Meanwhile, generalizations of Q-functions to deal with
data with multiple treatments as well as other type of outcome
(ordinal, censored outcomes) are interesting research topics as
well.
Supplementary Material
The online supplement contains additional simulation results, and the
proofs for the theorems discussed in the article.
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